Vet Solutions Aller G-3 Supplement is an Omega-3 fatty acid supplement for dogs. Omega-3 fatty acid is derived from fish oil.
An excellent supplementary source of Omega-3 fatty acids where dietary intake is inadequate or when the skin and coat condition indicate that supplementation would be of benefit to the animal. AllerG-3 contains the only fish oil to achieve USP ingredient verification.
For use in dogs where dietary intake is inadequate
or when the skin and coat condition indicate that
supplementation would be of benefit to the animal.
Fish oil yields the highest levels of EPA
EPA and AA compete for the same
enzymes (lipoxygenase and
cyclooxygenase) in the formation of
different types of eicosanoids/li>
Through the process of competitive
inhibition, EPA will displace AA
resulting in the formation of fewer
EPA derived eicosanoids inhibit the
activity of AA derived eicosanoids/li>
AllerG-3 contains fish oil, not flax seed oil
(flax seed oil is rich in Alpha-Linolenic Acid
(ALA) but contains no EPA)/li>
Anti-flammatory levels of EPA
cannot be achieved by consuming
ALA but can only be achieved by
The fish oil in AllerG-3 products is in the triglyceride (TG), or
natural form. In a recent study, EPA (Eicosapentaenoic
Acid) and DHA (Docosahexaenoic Acid) in TG form
has been shown to be 24% more bioavailable than either
the ethyl ester or free fatty acid forms1
. This research
directly contradicts the less recent citations used to promote
AllerG-3 products contain the only fish oil to achieve USP
ingredient verification. USP uses rigorous standards to
evaluate manufacturing and quality control systems and
test ingredient samples for compliance with identity,
strength, quality and purity claims as well as acceptable
contaminant limits. USP is a world-recognized, not-forprofit, independent authority that has set the official
standards for medicines, dietary supplements, and
ingredients in the United States since 1820.
In addition to USP verification, our fish oil meets or exceeds
the purity standards set forth in the CRN (Council for
Responsible Nutrition) Voluntary Monograph.
The standards set forth in the monograph are
consistent with current or emerging
European standards and limits
established under California’s
J. Dyerberg, et. al., Bioavailability of n-3 Fatty Acid Formulations in
n-3 Fatty Acids: Prevention and Treatment in Vascular Disease, 1995.